Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician’s prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
This report focuses on the Drugs for Malaria in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Leading Drugs for malaria Market Players:
– Guilin Pharmaceutical
– IPCA Laboratories
– Mylan Labs
– Sanofi Aventis
– Ajanta Pharma
Get Sample Copy of this Report @:
Global Drugs for malaria Market Segmentation:
Market Segment by Type, covers
– Aryl Aminoalcohol Compounds
– Antifolate Compounds
– Artemisinin Compounds
Market Segment by Applications, can be divided into
Market Segment by Regions, regional analysis covers
– North America (United States, Canada and Mexico)
– Europe (Germany, France, UK, Russia and Italy)
– Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
– South America (Brazil, Argentina, Colombia etc.)
– Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Avail Upto 40% discount on this report:
Scope of the Report:
The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.
For More enquiry:
Table of Contents
Global Drugs for malaria Market Research Report 2019-2025
Chapter 1: Industry Overview
Chapter 2: Drugs for malaria Market International and China Market Analysis
Chapter 3: Environment Analysis of Market.
Chapter 4: Analysis of Revenue by Classifications
Chapter 5: Analysis of Revenue by Regions and Applications
Chapter 6: Analysis of Drugs for malaria Market Revenue Market Status.
Chapter 7: Analysis of Industry Key Manufacturers
Chapter 8: Sales Price and Gross Margin Analysis of Market.
Chapter 9: Marketing Trader or Distributor Analysis of Market.
Chapter 10: Development Trend of Drugs for malaria Market 2019-2025.
Chapter 11: Industry Chain Suppliers of Market with Contact Information.
Chapter 12: New Project Investment Feasibility Analysis of Market.
Chapter 13: Conclusion of the Drugs for malaria Market Industry 2025 Market Research Report
If you need anything more than these then let us know and we will prepare the report according to your requirement.
About Research N Report:
Research N Reports is a new age market research firm where we focus on providing information that can be effectively applied. Today being a consumer driven market, companies require information to deal with the complex and dynamic world of choices. Where relying on a sound board firm for your decisions becomes crucial. Research N Reports specializes in industry analysis, market forecasts and as a result getting quality reports covering all verticals, whether be it gaining perspective on current market conditions or being ahead in the cut throat Global competition. Since we excel at business research to help businesses grow, we also offer consulting as an extended arm to our services which only helps us gain more insight into current trends and problems. Consequently we keep evolving as an all-rounder provider of viable information under one roof.
(Research N Reports)
10916, Gold Point Dr, Houston, TX, Pin – 77064,